Sex-specific association of estrogen receptor 2 polymorphisms with hepatitis C virus infection outcomes in a high-risk Chinese Han population

Infection, Genetics and Evolution

Volumn 28, Issue , 2014, Pages 118-124

  Cai, Li ^a   Gao, Chunfang ^b   Tang, Shaidi ^a   Wang, Jiajia ^a   Xue, Xingxin ^a   Yue, Ming ^c   Deng, Xiaozhao ^c   Su, Jing ^a   Peng, Zhihang ^a   Lu, Yan ^d   Zhang, Yun ^a,c   Wang, Jie ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b The 150th Central Hospital of People's Liberation Army   (China)

^c HUADONG RESEARCH INSTITUTE FOR MEDICINE AND BIOTECHNICS   (China)

^d SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Estrogen receptor 2; Hepatitis C virus; Outcome; Polymorphism; Susceptibility

Indexed keywords

ESTROGEN RECEPTOR BETA; 3' UNTRANSLATED REGION;

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; CASE CONTROL STUDY; CHRONICITY; CONTROLLED STUDY; ESR2 GENE; FEMALE; GENE; GENE INTERACTION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION DISTRIBUTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; 3' UNTRANSLATED REGION; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMISTRY; CHINA; CONFORMATION; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; HEPACIVIRUS; MIDDLE AGED; OUTCOME ASSESSMENT; PROGNOSIS; RISK; VIROLOGY;

3' UNTRANSLATED REGIONS; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DATABASES, GENETIC; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID CONFORMATION; ODDS RATIO; PATIENT OUTCOME ASSESSMENT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SEX FACTORS;

EID: 84907675549     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.09.024     Document Type: Article

References (44)

1. Alter M.J. Epidemiology of hepatitis C in the West. Semin. Liver Dis. 1995, 15:5-14.
2. Bakr I., Rekacewicz C., El Hosseiny M., Ismail S., El Daly M., El-Kafrawy S., Esmat G., Hamid M.A., Mohamed M.K., Fontanet A. Higher clearance of hepatitis C virus infection in females compared with males. Gut 2006, 55:1183-1187.
3. Bhat R.A., Harnish D.C., Stevis P.E., Lyttle C.R., Komm B.S. A novel human estrogen receptor beta: identification and functional analysis of additional N-terminal amino acids. J. Steroid Biochem. Mol. Biol. 1998, 67:233-240.
4. Chu S., Nishi Y., Yanase Y., Nawata H., Fuller P.J. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells. Mol. Endocrinol. 2004, 18:1919-1928.
5. Codes L., Asselah T., Cazals-Hatem D., Tubach F., Vidaud D., Parana R., Bedossa P., Valla D., Marcellin P. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut 2007, 56:390-395.
6. Di Martino V., Lebray P., Myers R.P., Pannier E., Paradis V., Charlotte F., Moussalli J., Thabut D., Buffet C., Poynard T. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 2004, 40:1426-1433.
7. Glisovic T., Bachorik J.L., Yong J., Dreyfuss G. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 2008, 582:1977-1986.
8. Goulart A.C., Zee R.Y., Rexrode K.M. Association of estrogen receptor 2 gene polymorphisms with obesity in women (obesity and estrogen receptor 2 gene). Maturitas 2009, 62:179-183.
9. Huang H., He J., Yuan Y., Aoyagi E., Takenaka H., Itagaki T., Sannomiya K., Tamaki K., Harada N., Shono M., Shimizu I., Takayama T. Opposing effects of estradiol and progesterone on the oxidative stress-induced production of chemokine and proinflammatory cytokines in murine peritoneal macrophages. J. Med. Invest. 2008, 55:133-141.
10. Iwasaki M., Hamada G.S., Nishimoto I.N., Netto M.M., Motola J., Laginha F.M., Kasuga Y., Yokoyama S., Onuma H., Nishimura H., Kusama R., Kobayashi M., Ishihara J., Yamamoto S., Hanaoka T., Tsugane S. Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians. Cancer Sci. 2009, 100:927-933.
11. Kao J.H., Chen D.S. Transmission of hepatitis C virus in Asia: past and present perspectives. J. Gastroenterol. Hepatol. 2000, 15(Suppl.):E91-E96.
12. Karlson E.W., Chibnik L.B., McGrath M., Chang S.C., Keenan B.T., Costenbader K.H., Fraser P.A., Tworoger S., Hankinson S.E., Lee I.M., Buring J., De Vivo I. A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis. Arthritis Res. Ther. 2009, 11:R97.
13. Karpuzoglu E., Zouali M. The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management. Clin. Rev. Allergy Immunol. 2011, 40:16-26.
14. Kuersten S., Goodwin E.B. Linking nuclear mRNP assembly and cytoplasmic destiny. Biol. Cell 2005, 97:469-478.
15. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect. 2011, 17:107-115.
16. Lee S.W., Song J.H., Choi W.S., Yoon J.H., Kim O., Park Y.G., Nam S.W., Lee J.Y., Park W.S. The single nucleotide polymorphism (SNP) of the estrogen receptor-beta gene, rs1256049, is associated with knee osteoarthritis in Korean population. Knee 2014, 21:242-246.
17. Liang T.J., Rehermann B., Seeff L.B., Hoofnagle J.H. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 2000, 132:296-305.
18. Lu G., Shimizu I., Cui X., Itonaga M., Tamaki K., Fukuno H., Inoue H., Honda H., Ito S. Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats. Life Sci. 2004, 74:897-907.
19. Pelzer T., Neumann M., de Jager T., Jazbutyte V., Neyses L. Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta. Biochem. Biophys. Res. Commun. 2001, 286:1153-1157.
20. Pinkus R., Weiner L.M., Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J. Biol. Chem. 1996, 271:13422-13429.
21. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol. Aspects Med. 2000, 21:49-98.
22. Ponglikitmongkol M., Green S., Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J. 1988, 7:3385-3388.
23. Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997, 349:825-832.
24. Poynard T., Ratziu V., Charlotte F., Goodman Z., McHutchison J., Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J. Hepatol. 2001, 34:730-739.
25. Puoti, C., Guarisco, R., Bellis, L., Spilabotti, L., 2009. Diagnosis, management, and treatment of hepatitis C. Hepatology 50, 322; author reply 324-325.
26. Putnik M., Zhao C., Gustafsson J.A., Dahlman-Wright K. Effects of two common polymorphisms in the 3' untranslated regions of estrogen receptor beta on mRNA stability and translatability. BMC Genet. 2009, 10:55.
27. Rexrode K.M., Ridker P.M., Hegener H.H., Buring J.E., Manson J.E., Zee R.Y. Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. Clin. Chem. 2007, 53:1749-1756.
28. Rosenkranz K., Hinney A., Ziegler A., Hermann H., Fichter M., Mayer H., Siegfried W., Young J.K., Remschmidt H., Hebebrand J. Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants. J. Clin. Endocrinol. Metabol. 1998, 83:4524-4527.
29. Ryan J., Carriere I., Carcaillon L., Dartigues J.F., Auriacombe S., Rouaud O., Berr C., Ritchie K., Scarabin P.Y., Ancelin M.L. Estrogen receptor polymorphisms and incident dementia: the prospective 3C study. Alzheimer's Dement. 2014, 10:27-35.
30. Shimizu I., Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol. Res. 2007, 37:239-247.
31. Speir E., Yu Z.X., Takeda K., Ferrans V.J., Cannon R.O. Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells. Circulation 2000, 102:2990-2996.
32. Stein B., Yang M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol. Cell. Biol. 1995, 15:4971-4979.
33. Szostak E., Gebauer F. Translational control by 3'-UTR-binding proteins. Brief. Funct. Genomics 2013, 12:58-65.
34. Tang, S., Yue, M., Wang, J., Su, J., Yu, R., Zhou, D., Xu, K., Cai, L., Zhang, Y., Wang, J., 2014. Association of genetic variants in estrogen receptor alpha with HCV infection susceptibility and viral clearance in a high-risk Chinese population. Eur. J. Clin. Microbiol. Infect. Dis.
35. The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy. Int. J. Cancer 2010, 126:2935-2946.
36. Thomas, D.L., Astemborski, J., Rai, R.M., Anania, F.A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K.E., Strathdee, S.A., Johnson, L., Laeyendecker, O., Boitnott, J., Wilson, L.E., Vlahov, D., 2000. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284, 450-456.
37. Tyree C.M., Zou A., Allegretto E.A. 17beta-Estradiol inhibits cytokine induction of the human E-selectin promoter. J. Steroid Biochem. Mol. Biol. 2002, 80:291-297.
38. Villa E., Colantoni A., Grottola A., Ferretti I., Buttafoco P., Bertani H., De Maria N., Manenti F. Variant estrogen receptors and their role in liver disease. Mol. Cell. Endocrinol. 2002, 193:65-69.
39. Wands J. Hepatocellular carcinoma and sex. New Engl. J. Med. 2007, 357:1974-1976.
40. Wu H., Xu L., Chen J., Hu J., Yu S., Hu G., Huang L., Chen X., Yuan X., Li G. Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study. BMC Cancer 2012, 12:276.
41. Yu K.D., Rao N.Y., Chen A.X., Fan L., Yang C., Shao Z.M. A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk. Breast Cancer Res. Treat. 2011, 126:37-45.
42. Yuan Y., Shimizu I., Shen M., Aoyagi E., Takenaka H., Itagaki T., Urata M., Sannomiya K., Kohno N., Tamaki K., Shono M., Takayama T. Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C. World J. Gastroenterol. 2008, 14:2200-2207.
43. Zhou Y., Shimizu I., Lu G., Itonaga M., Okamura Y., Shono M., Honda H., Inoue S., Muramatsu M., Ito S. Hepatic stellate cells contain the functional estrogen receptor beta but not the estrogen receptor alpha in male and female rats. Biochem. Biophys. Res. Commun. 2001, 286:1059-1065.
44. Zhou Y.J., Yin D.M., Chen H.S., Shi J.H., Sha B.X., Wang X. Inhibitory effects of idoxifene on hepatic fibrosis in rats. Acta Pharmacol. Sin. 2005, 26:581-586.